Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Alzheimer disease (AD) is an age-related neurodegenerative disorder, characterized histopathologically by the presence of senile plaques (SP), neurofibrillary tangles and synapse loss in selected brain regions. Positron emission tomography (PET) studies of glucose metabolism revealed decreased energetics in brain of subjects with AD and arguably its earliest form, mild cognitive impairment (MCI), and this decrease correlated with brain structural studies using MRI. The main component of senile plaques is amyloid beta-peptide (Aβ), a 40–42 amino acid peptide that as oligomers is capable of inducing oxidative stress under both in vitro and in vivo conditions and is neurotoxic. In the mitochondria isolated from AD brain, Aβ oligomers that correlated with the reported increased oxidative stress markers in AD have been reported. The markers of oxidative stress have been localized in the brain regions of AD and MCI that show pathological hallmarks of this disease, suggesting the possible role of Aβ in the initiation of the free-radical mediated process and consequently to the build up oxidative stress and AD pathogenesis. Using redox proteomics our laboratory found a number of oxidatively modified brain proteins that are directly in or are associated with the mitochondrial proteome, consistent with a possible involvement of the mitochondrial targeted oxidatively modified proteins in AD progression or pathogenesis. The precise mechanistic link between mitochondrial oxidative damage and role of oligomeric Aβ has not been explicated. In this review, we discuss the role of the oxidation of mitochondria-relevant brain proteins to the pathogenesis and progression of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“…observations from familial Alzheimer disease [FAD] (Hardy and Selkoe 2002) that showed that mutations of the genes of amyloid precursor protein (Goate et al. 1991), presenilin-1 and presenilin-2 (Cruts et al. 1998) leads to increased accumulation of fibrillar Aβ in the brain (Hardy and Selkoe…”
BackgroundOxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 1×
“…1997), protein oxidation (Butterfield and Stadtman 1997; Good et al. 1996; Hensley et al. 1995; Smith et al. 1997), advanced glycation end products (Vitek et al. 1994), and oxidation of nucleic acids (Gabbita et al. 1998; Lovell and Markesbery 2001; Mecocci et al. 1994; Nunomura et al. 1999, 2001).”
BackgroundOxygen radicals and human disease
CROSS, C. E., HALLIWELL, B., BORISH, E. T., PRYOR, W. A., AMES, B. N., SAUL, R. L., McCORD, J. M., & HARMAN, D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-526 · Cited by 1,856
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Self-citationManczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104 · cited 1×
“…and oligomers in the mitochondrial membranes isolated from the AD brain and brain of animal models of AD (Caspersen et al. 2005; Crouch et al. 2007; Manczak et al. 2006), which suggest possible alterations in mitochondrial structure and function as one of the mechanism(s) of AD pathogenesis.”
BackgroundAmyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046 · cited 1×
“…KY 40506-0059, USA R. Sultana :D. A. Butterfield Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA oligomers of Aβ are the actual toxic species of this peptide rather than Aβ fibrils (Drake et al. 2003; Lambert et al. 2001; Oda et al. 1995; Walsh et al. 1999).”
BackgroundOxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · cited 1×
“…1997), protein oxidation (Butterfield and Stadtman 1997; Good et al. 1996; Hensley et al. 1995; Smith et al. 1997), advanced glycation end products (Vitek et al. 1994), and oxidation of nucleic acids (Gabbita et al. 1998; Lovell and Markesbery 2001; Mecocci et al. 1994; Nunomura et al. 1999, 2001).”
BackgroundAdvanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806 · cited 1×
“…1997), protein oxidation (Butterfield and Stadtman 1997; Good et al. 1996; Hensley et al. 1995; Smith et al. 1997), advanced glycation end products (Vitek et al. 1994), and oxidation of nucleic acids (Gabbita et al. 1998; Lovell and Markesbery 2001; Mecocci et al. 1994; Nunomura et al. 1999, 2001).”
BackgroundHensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779
Self-citationMitochondrial abnormalities in Alzheimer brain: Mechanistic implications
Bubber, P., Haroutunian, V., Fisch, G., Blass, J. P., & Gibson, G. E. (2005) · Annals of Neurology · doi:10.1002/ana.20474 · Cited by 622
Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581
Self-citationButterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564
Self-citationEvidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
Self-citationLauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464 · cited 4×
“…that HNE modification of the glutamate transporter (Glt-1 or EAAT), glutathione-S-transferase (GST), and multi-drug resistant protein (MRP-1) (Lauderback et al. 2001a; Sultana and Butterfield 2004) leads to decrease function of these proteins and consequently lead to excitotoxic cell death…”
BackgroundInfluentialSelf-citationChapter 7 Protein Oxidation Processes in Aging Brain
Butterfield, D. A., & Stadtman, E. R. (1997) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60057-7 · Cited by 390
Self-citationButterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377 · cited 4×
“These results suggest the accumulation of oxidative stress markers (Butterfield et al. 2006b; Ding et al. 2006; Keller et al. 2005) in MCI brain, and are consistent with the notion that oxidative stress could be an early event in the progression of MCI to AD.”
BackgroundResultInfluentialSelf-citationDrake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371 · cited 1×
“…KY 40506-0059, USA R. Sultana :D. A. Butterfield Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA oligomers of Aβ are the actual toxic species of this peptide rather than Aβ fibrils (Drake et al. 2003; Lambert et al. 2001; Oda et al. 1995; Walsh et al. 1999).”
BackgroundIdentification of nitrated proteins in Alzheimer’s disease brain using a redox proteomics approach
Sultana, R., Poon, H. F., Cai, J., Pierce, W. M., Merchant, M., Klein, J. B., Markesbery, W. R., & Butterfield, D. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.10.004 · Cited by 364 · cited 11×
“Among these brain proteins, GAPDH, aconitase, VDAC, ATP synthase-alpha chain, lactate dehydrogenase (LDH), beta-actin, and alphatubulin, are either mitochondrial proteins or are known to interact with mitochondria (Aksenov et al. 2000; Castegna et al. 2002, 2003; Reed et al. 2008; Sultana et al. 2006a, b).”
BackgroundInfluentialSelf-citationOda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352
Bosetti, F. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00314-1 · Cited by 348
Different Mechanisms of Oxidative Stress and Neurotoxicity for Alzheimer‘s Aβ(1−42) and Aβ(25−35)
Varadarajan, S., Kanski, J., Aksenova, M., Lauderback, C., & Butterfield, D. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010452r · Cited by 346 · cited 1×
“…into the membrane, it may initiate the process of lipid peroxidation (Butterfield and Boyd-Kimball 2005; Butterfield et al. 2007a; Kanski et al. 2002; Lauderback et al. 2001b; Varadarajan et al. 2001) that may eventually lead to damage of both mitochondrial membrane proteins and lipids (Fig.”
BackgroundSelf-citationMechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s disease
Atamna, H., & Frey, W. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.06.001 · Cited by 278
Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., & Butterfield, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031161.x · Cited by 270
Self-citationIncreased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment
Wang, J., Markesbery, W. R., & Lovell, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03615.x · Cited by 260 · cited 1×
“…(fapyguanine), 8-hydroxyadenine, 4,6-diamino-5-formamidopyrimidine (fapyadenine) and 5-hydroxycytosine] (Bader Lange et al. 2008; Butterfield et al. 2006a, b; Keller et al. 2005; Markesbery et al. 2005; Migliore et al. 2005; Wang et al. 2006; Williams et al. 2006).”
BackgroundReed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257 · cited 9×
“1) (Aksenov et al. 2000; Castegna et al. 2002, 2003; Reed et al. 2008; Sultana et al. 2006a, b).”
BackgroundInfluentialSelf-citationButterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246 · cited 4×
“These results suggest the accumulation of oxidative stress markers (Butterfield et al. 2006b; Ding et al. 2006; Keller et al. 2005) in MCI brain, and are consistent with the notion that oxidative stress could be an early event in the progression of MCI to AD.”
BackgroundResultInfluentialSelf-citationAlzheimer’s disease can be accurately diagnosed in very mildly impaired individuals
Salmon, D. P., Thomas, R. G., Pay, M. M., Booth, A., Hofstetter, C. R., Thal, L. J., & Katzman, R. (2002) · Neurology · doi:10.1212/wnl.59.7.1022 · Cited by 189 · cited 1×
“Alzheimer’s disease (AD) is an age-related neurodegenerative disorder, characterized clinically by the impairment of cognitive functions and behavioral alterations (Katzman and Saitoh 1991; Salmon et al. 2002).”
BackgroundDecreased RNA, and Increased RNA Oxidation, in Ribosomes from Early Alzheimer’s Disease
Ding, Q., Markesbery, W. R., Cecarini, V., & Keller, J. N. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9071-5 · Cited by 140 · cited 1×
“These results suggest the accumulation of oxidative stress markers (Butterfield et al. 2006b; Ding et al. 2006; Keller et al. 2005) in MCI brain, and are consistent with the notion that oxidative stress could be an early event in the progression of MCI to AD.”
ResultClementi, M. E., Pezzotti, M., Orsini, F., Sampaolese, B., Mezzogori, D., Grassi, C., Giardina, B., & Misiti, F. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.137 · Cited by 105
Lambert, J.-C., Mann, D. M. A., Harris, J. M., Chartier-Harlin, M.-C., Cumming, A., Coates, J., Lemmon, H., StClair, D., Iwatsubo, T., & Lendon, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.6.353 · Cited by 61
Cited by
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances.
Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00376-6 · Cited by 1,274
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Ferulic acid: Pharmacological and toxicological aspects
Mancuso, C., & Santangelo, R. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.024 · Cited by 572
Energy metabolism and inflammation in brain aging and Alzheimer’s disease
Yin, F., Sancheti, H., Patil, I., & Cadenas, E. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.200 · Cited by 538
Sultana, R., Perluigi, M., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.027 · Cited by 478
“TheoligomericformofAbspeciesinterferesinmole- cularandbiochemicalalterationsinADmoresothantheextracellular ,insolubleamyloiddeposits[156] [157] [158],suggestingthat Ab-inducedmitochondrialdysfunctioncanplayamajorrolein ADprogressionandpathogenesis[159] [160] [161].”
Self-citation
Metadata
- Authors
- Sultana, R., & Butterfield, D. A.
- Venue
- Journal of Bioenergetics and Biomembranes
- Published
- 2009-09-24
- Volume
- 41
- Issue
- 5
- Pages
- 441-446
- ISSN
- 0145-479X (ISSN-L)
- 1573-6881
- OpenAlex
- W2016429383
- Cited by
- 108
- References
- 31
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.